MAP Pharmaceuticals
Get verified emails for MAP Pharmaceuticals employees
About MAP Pharmaceuticals
|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
US
|
|
MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX™ inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
|
MAP Pharmaceuticals Alternatives
Frequently Asked Questions about MAP Pharmaceuticals
Who is the CEO of MAP Pharmaceuticals?
Ashish Kesari is the CEO of MAP Pharmaceuticals. To contact Ashish Kesari email at [email protected] or [email protected].
Who are the decision makers in MAP Pharmaceuticals?
The decision makers in MAP Pharmaceuticals are Ashish Kesari, Ashish Kesari, Larrain Taberna, etc. Click to Find MAP Pharmaceuticals decision makers emails.
MAP Pharmaceuticals Staff Directory
Search MAP Pharmaceuticals Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
